Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,289
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
for
Plaque Psoriasis
Location: Fairborn OH, Canton OH, Mayfield Heights OH,
Sponsor: Takeda
Sex: All
Age: 4 - 17
Code: NCT07250802
Phase3, Recruiting
Gene Expression Changes In Young and Geriatric Skin
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for
Heart Failure
Location: Marion OH, Richmond IN, Ypsilanti MI, Indianapolis IN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06935370
Phase3, Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Marion OH, Richmond IN, Maumee OH, Indianapolis IN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase2, Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
for
Atrial Fibrillation (AF)
Location: Marion OH, Farmington Hills MI, Bloomfield Hills MI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07430956
Phase3, Recruiting
New
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
for
Atrial Fibrillation (AF)
Location: Marion OH, Farmington Hills MI, Bloomfield Hills MI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07626411
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Springfield OH, Richmond IN, Canton OH, Toledo OH,